Amber Lea Medlin LCSWA, LCAS
Counselor/Therapist | Addiction (Substance Use Disorder)
101 CABARRUS AVE E STE 200 CONCORD NC, 28025About
Amber Medlin is an Addiction Medicine Counselor in CONCORD, NC. Amber evaluates patients using many different procedures, in order to determine what treatments must be carried out in order to properly assess their symptoms. Addiction Medicine counselors provide patient care and consultation for each patient and their families.
Provider Details
Amber Lea Medlin LCSWA, LCAS's Practice location
CONCORD, NC 28025Get Direction
Amber Lea Medlin LCSWA, LCAS's reviews
Write ReviewRecommended Articles
- Learning About the Beck Depression Inventory
Depression and AnxietyDepression and anxiety are disorders that are different from each other, but people suffering from depression often have symptoms that closely resemble those of anxiety. The disorder, in fact, starts out as anxiety, and if not treated at the right time with the right diagnosis,...
- How Can I Tell the Difference Between the Flu and a Cold?
With similar symptoms, these two conditions are often very difficult to distinguish from each other. Look closer and you can tell them apart with ease. Now, why should you know whether it is a cold or a flu? Understanding the condition would help you to take the right medications. Moreover, it will...
- Does Breast Cancer Occur More Often in Certain Areas of the US
Breast cancer is the second most common cancer in the United States, after skin cancers. Currently, it affects more than 1 in 10 women worldwide. The two most common risk factors of breast cancer are being female and becoming older. If you are a woman and you have a relative (mother, sister, or...
- Treatments for Rosacea
Treatment for rosacea is determined by which sub-type you have. Although there is no cure for the condition, there are several treatment options available to control signs and symptoms. Depending on symptoms, your doctor will tailor a treatment plan that best suits you.There are four sub-types of...
- New Drug for Parkinson's Disease Approved by FDA
The US Food and Drug Administration (FDA) recently passed a new drug called amantadine extended release capsules to treat dyskinesia in those who have Parkinson’s disease and are also on medication therapy. The Michael J. Fox Foundation recently created the UNDRS or Unified Dyskinesia Rating...
- Common Antioxidant May Slow Multiple Sclerosis Progression
To date, multiple sclerosis (MS), a chronic neurological condition, affects more than 2.3 million individuals worldwide. The immune system mistakenly attacks the myelin, which is the protective layer that surrounds the nerve fibers. This, in turn, disrupts the regular nerve signaling between the...